Literature DB >> 19898790

[The risk of stent thrombosis in the perioperative setting].

Martin Norbert Vicenzi1.   

Abstract

Percutaneous coronary interventions associated with a need for long-term dual anti-platelet therapy are steadily increasing. Accordingly, reports of severe perioperative complications in this high-risk group of patients are also increasing. Complications can be categorized into two groups: coronary ischemia or myocardial infarction due to acute stent thrombosis or increased blood loss. Risk of stent thrombosis is higher compared to the risk of bleeding. The article discusses the perioperative management based on an informative case report and recent evidence: Elective surgery has to be postponed until the end of dual anti-platelet therapy. Management of patients planned for semi-elective surgery should be individualized with interdisciplinary consensus. If clopidogrel is withdrawn, aspirin should be administered throughout the perioperative period. Careful surgical technique is required. If surgery is planned within 12 months, implantation of bare metal stents is recommended.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898790     DOI: 10.1007/s10354-009-0715-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  26 in total

Review 1.  Evaluation of platelet function by flow cytometry.

Authors:  Alan D Michelson
Journal:  Pathophysiol Haemost Thromb       Date:  2006

2.  Risk of noncardiac surgery after coronary drug-eluting stent implantation.

Authors:  P Alexander Compton; Ahmad A Zankar; Adebola O Adesanya; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

Review 3.  Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis.

Authors:  W Burger; J-M Chemnitius; G D Kneissl; G Rücker
Journal:  J Intern Med       Date:  2005-05       Impact factor: 8.989

4.  Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.

Authors:  Emile Ferrari; Mustapha Benhamou; Pierre Cerboni; Baudouy Marcel
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

5.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

6.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

Authors:  G L Kałuza; J Joseph; J R Lee; M E Raizner; A E Raizner
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

Review 7.  Current options in platelet function testing.

Authors:  Alan D Michelson; Andrew L Frelinger; Mark I Furman
Journal:  Am J Cardiol       Date:  2006-09-29       Impact factor: 2.778

8.  Risks of noncardiac surgery after coronary stenting.

Authors:  Proddutur R Reddy; Paul T Vaitkus
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

9.  Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Authors:  Paul A Gurbel; Kevin P Bliden; Joseph DiChiara; Justin Newcomer; Willy Weng; Nagaraj K Neerchal; Tania Gesheff; Srivasavi K Chaganti; Amena Etherington; Udaya S Tantry
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.